Prognostic Role of Androgen Receptor Expression in HER2+ Breast Carcinoma Subtypes

HER2+ breast cancer (BC) is an aggressive subtype representing a genetically and biologically heterogeneous group of tumors resulting in variable prognosis and treatment response to HER2-targeted therapies according to estrogen (ER) and progesterone receptor (PR) expression. The relationship with an...

Descripción completa

Detalles Bibliográficos
Autores principales: Orrù, Sandra, Pascariello, Emanuele, Sotgiu, Giovanni, Piras, Daniela, Saderi, Laura, Muroni, Maria Rosaria, Carru, Ciriaco, Arru, Caterina, Mocci, Cristina, Pinna, Giampietro, Barbara, Raffaele, Cossu-Rocca, Paolo, De Miglio, Maria Rosaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773834/
https://www.ncbi.nlm.nih.gov/pubmed/35052843
http://dx.doi.org/10.3390/biomedicines10010164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773834/
https://www.ncbi.nlm.nih.gov/pubmed/35052843
http://dx.doi.org/10.3390/biomedicines10010164

Ejemplares similares